PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users

Cited by (106)

Items 101–106 of 106

1. Stimulant Treatment Gap in ADHD Patients with Heroin Use Disorder: Clinical and Behavioural Consequences
   A. Pallucchini, Maurizio Varese, Irene Pergentini, S. Gemignani, Elisa Parapetto, I. Maremmani, A. Maremmani · 2025 · International Journal of Environmental Research and Public Health
2. Effort and substance use: differentiating tobacco use through reinforcement learning of effort based decision making
   Kasey P. Spry, Jazmyne James, Alison H. Oliveto, Michael J. Mancino, Kenneth T. Kishida, Merideth A. Addicott · 2026 · Journal of Computational Neuroscience
3. Marqueurs moléculaires de l'escalade de consommation d'héroïne et de la rechute sous un traitement de substitution, la méthadone
   Loïc Clémenceau · 2023
4. Blunted modulation of hierarchical brain organization in opioid use disorder
   Dardo G. Tomasi, Peter Manza, Şükrü Barış Demiral, Natasha T. Giddens, Annabelle M. Belcher, Weizheng Yan, Kylee Miller, Faith Veenker, Christina Lildharrie, Michele-Vera Yonga et al. · 2026 · Research Square
5. Dual hypocretin receptor antagonism reduces oxycodone seeking and attenuates aberrant dopamine transporter function during abstinence
   Kyle R. Samson, Alison R. Bashford, Rodrigo A. España · 2026 · Neuropharmacology
6. Parkinson's disease under dopamine replacement therapy as a human framework for studying addiction‐relevant mechanisms
   Vanessa Fleury, Elvira Pirondini, Damien Benis, Tiffany Corbet, Gabriel Thorens, Christian Lüscher, Paul Krack · 2026 · Psychiatry and Clinical Neurosciences